ADAM Proteins- Therapeutic Potential in Cancer
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
720-732
Author(s):
Xinjie Lu, Dong Lu, Mike Scully and Vijay Kakkar
The PIK3CA Gene as a Mutated Target for Cancer Therapy
Journal:
Current Cancer Drug Targets
Volume:
8
Page:
733-740
Author(s):
John P. Gustin, David P. Cosgrove and Ben Ho Park
Strategies for Targeting Lentiviral Vectors
Journal:
Current Gene Therapy
Volume:
8
Page:
449-460
Author(s):
Cecilia Frecha, Judit Szecsi, Francois-Loic Cosset and Els Verhoeyen
Applications of Lentiviral Vectors for Biology and Gene Therapy of Neurological Disorders
Journal:
Current Gene Therapy
Volume:
8
Page:
461-473
Author(s):
Cecilia Lundberg, Tomas Bjorklund, Thomas Carlsson, Johan Jakobsson, Philippe Hantraye, Nicole Deglon and Deniz Kirik
Applications of Lentiviral Vectors for shRNA Delivery and Transgenesis
Journal:
Current Gene Therapy
Volume:
8
Page:
483-488
Author(s):
Oded Singer and Inder M. Verma
CDC25A: A Rebel Within the CDC25 Phosphatases Family?
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
825-831
Author(s):
Anne Fernandez-Vidal, Anne Mazars and Stephane Manenti
In Vivo Roles of CDC25 Phosphatases: Biological Insight into the Anti-Cancer Therapeutic Targets
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
832-836
Author(s):
Hiroaki Kiyokawa and Dipankar Ray
Cdc25A Protein Phosphatase: A Therapeutic Target for Liver Cancer Therapies
Journal:
Anti-Cancer Agents in Medicinal Chemistry
Volume:
8
Page:
863-871
Author(s):
Z. Wang, S. Kar and B. I. Carr
Cancer Stem Cells: How can we Target them?
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
3171-3184
Author(s):
Ivan Ischenko, Hendrik Seeliger, Moshe Schaffer, Karl-Walter Jauch and Christiane J. Bruns
PPARγ and Early Human Placental Development
Journal:
Current Medicinal Chemistry
Volume:
15
Page:
3011-3024
Author(s):
Thierry Fournier, Patrice Therond, Karen Handschuh, Vassilis Tsatsaris and Daniele Evain-Brion